Further step ‘Towards Zero’ as suicide prevention grants open

The Morrison Government is taking a further step towards reducing the number of lives lost to suicide in Australia, by providing $8 million to support research aimed at identifying effective approaches to suicide prevention.   The funding is being provided through the Government’s Million Minds Mission, with the grant round officially opening on 28 November…

Increased Support for indigenous diabetics

Aboriginal and Torres Strait Islander people with or at risk of diabetes-related foot problems and amputations, will receive increased support thanks to a new Morrison Government-funded initiative.   The Government will invest $6 million over two years to fund the Aboriginal and Torres Strait Islander Diabetic Foot Complication Project.   The Project aims to reduce…

Response to Aged Care Royal Commission Interim Report

The Morrison Government is taking strong action to respond to the three priority areas identified in the Aged Care Royal Commission’s Interim Report released on October 31, by increasing home care packages, reducing chemical restraints, and getting younger people out of residential aged care. The Royal Commission’s interim report is clear – as a country,…

Doorstop – Sydney

E&OE…                       Topics: New medicines to be listed on the PBS; David Roberts   GREG HUNT: I’m delighted to be here today at the Royal North Shore Private Hospital with Trent Zimmerman, Member for North Sydney, Professor Stephen Clarke, Dr Matthew Greenwood and Bill Petch who is from the Leukaemia Foundation.   We’re really thrilled…

Game changing cancer medicines now within reach for 2,200 Australians

Australians living with non-small cell lung cancer and early stage acute lymphoblastic leukaemia will be able to access better treatment options with new listings on the Pharmaceutical Benefits Scheme (PBS) coming into effect on 1 December 2019. More than 2,200 patients with metastatic non-small cell lung cancer will now be able to access Keytruda® (pembrolizumab)…